We are excited to be present at the #EBMT24 Congress, in Glasgow. We look forward to welcoming you to our booth (E11), where you will be able to speak to our medical team about our clinical program and open trials. #MiltenyiBiomedicine
Miltenyi Biomedicine’s Post
More Relevant Posts
-
TTVR is coming really fast. Learn how to perform it with new forthcoming devices
EuroPCR 2024 Paris is just around the corner! If you are passionate about the field of structural heart, you are more than welcome to meet with us there! Venus Medtech is rapidly advancing in the development of replacement valves for all heart valves. Our solutions stand at the forefront of cardiac innovation, designed for those who need them most and the doctors who care for them. We’re actively enrolling patients in numerous registration studies and are eager to discuss how you can be part of this pioneering journey. Reach out to us via DM or email at info@cardiovalve.com to discover how you can help shape the future of cardiac care. See you in Paris. May 14-17! 💙🤍❤️ #venusmedtech #TTVR #TMVR #TAVI #PAVI
To view or add a comment, sign in
-
Know before you go: #CTAD23 is set to kick off tomorrow, and we’ve prepared a host of activities and information sessions that you won’t want to miss. Find our schedule of events and activities in our latest press release. Read the press release for our CTAD plan of activities: https://ow.ly/qiXs50PZaNS #AlzheimersDisease #ClinicalTrials
To view or add a comment, sign in
-
Product Manager-Peripheral Intervention at Marcus Medical Distribution Partner for Cook Medical and Getinge
Marcus Medical and Cardionovum have you covered to optimize vascular access and circuit patency for the haemodialysis patient.
The VASSA Congress 2023 is over! We would like to congratulate Prof. Matteo Tozzi for showing the clinical outcomes of his APERTO 600 analysis, in which more than 600 APERTO® DCBs have been used in ArteriousVenous Fistula (AVFs) and ArteriousVenous Grafts (AVGs), including a large number of Central Vein Stenosis (CVS). Thanks to our Partner MARCUS MEDICAL for representing us and making this conference a great success. More info about APERTO® OTW can be found at: https://lnkd.in/dD4mQiP #Cardionovum #APERTO #DCB #Safepax #drugcoatedballoon #AVF #AVG #CVS #VASSA2023 #vascularaccess #Lifedeservesthebest
To view or add a comment, sign in
-
-
It’s 𝕆𝕔𝕥𝕠𝕓𝕖𝕣!! So that means 🎃+🍂🍁+☕️ AND T̳C̳T̳ !!! 🥳🤓🙌🏼 So many exciting things—so be sure to: Stop by our TCT hub Tuesday at 5:00 pm, as we celebrate hitting our first milestone of enrolling 1,000 patients in DEFINE GPS, a global multi-center study to assess superiority of PCI procedures guided by Co-registered iFR and interventional angiography. https://lnkd.in/gY-_GTBE
To view or add a comment, sign in
-
-
Congratulations to Mindable Health for their second #DiGA being listed "Mindable: Soziale Phobie". This is also the 50th active DiGA on the #BfArM registry - a great success for all DiGA manufacturers and patients. Especially interesting are the following facts: 🔀 In 2023 - for the very first time - the number of #permanently listed DiGAs exceeds the number of #preliminarily listed DiGAs. So, the often anticipated mass exodus of preliminarily listed DiGAs that fail in their evidence studies did not happen! Surely, there have been a couple of de-listings, but this is rather the exception than the standard. 🚀 Since 3 years, the BfArM registry is continously growing and there are many more potential DiGAs on the horizon. Did the early predictions of 100+ reimbursable DTx in Germany come true? No. Were these predictions ambitious? Yes. But is the current state of 50 reimbursable DiGAs decent and a success? Absolutely YES. ✔ I am looking forward to celebrate the next 50 DiGAs on the registry - making it finally 100 DTx in Germany. #digitalhealth #BfArM #innovation Alexander Voigt Vincent Erdmann Axel Meiling
To view or add a comment, sign in
-
-
📢 Last week PulseCath closed a great EuroPCR again. As every year, great interest, many fruitful meetings, discussions and contacts. Some highligths: 🚩E-poster - Pulsatile mechanical circulatory support in high-risk PCI: results of a large multicentric registry - 293 cases assisted by iVAC 2L - Marcelo B. Bastos MD MHSc 🎤 3 iVAC 2L case presentations during the congress: 👉 One Last Time - K. Kaniappan 👉 Cardiogenic shock and three-vessel disease – I. Narbute 👉 Sheathless use of pulsatile percutaneous left ventricular assist device - S. Maggio 🚩2 Satellite Advisory and Experience Board meetings with KOL’s from Europe, China and Asian Pacific 🚩 Glimpse into the future - proof of concept Pulsatile Ventricular Assist Platform – pVAP 🤝 Thanks to everyone who joined us to discover and learn more about iVAC 2L, pulsatile percutaneous ventricular assist device and complex High-Risk PCI. We embrace this exciting journey and near future. Oren Malchin Ron Malchin Maja Krizaj Chrisna De Wet Helena Podrzaj uwe p. kasten Marleen van Mastwijk #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI #europcr2024
To view or add a comment, sign in
-
Excited to be headed to #himss24 to bring #Osler to American hospitals! Most OR scheduling at hospitals is still done manually. It can take weeks or months of work to get them prepared, and they often can't be changed on short notice. This results in wasted OR time and less efficient hospital operation. It also means so much time is spent finding a schedule that *works* that there's no time to think critically about how the schedule can be *better*. Osler helps on both fronts: - it makes generating valid schedules possible in seconds, so a hospital can react quickly to changes in their OR and surgeon availability - it provides data-driven feedback and suggestions to help create better schedules - it provides easy-to-use tools and clear visuals so that scheduling staff can identify areas of improvement themselves We're helping bring OR scheduling into the modern age, and helping thousands more people get their surgeries done in the process!
The Osler team is thrilled to announce that we will be attending #HIMSS24 in Orlando, March 11-15! To learn about how Osler can increase your surgical throughput by 4-10%, you can find Alexander Salgo, Dan Desjardins, PhD, and Gabrielle Mehltretter in the Ontario booth, #911 Feel free to check out our website in the meantime to learn more about Osler's capabilities https://lnkd.in/guTViGGR
To view or add a comment, sign in
-
-
Thanks for the reminder, I still have to finish my slides - CIRMS is a unique experience for individuals involved with #medicaldevices and irradiation, with plenaries on new techniques and technologies for radiation processing, advances in isotope and machine based radiation with an optional tour of NIST facilities following the conference. I'll be presenting a comparison of physical vs virtual dose mapping including some variables and product configurations that could be more accurately dose mapped using either technology.
Join us at the 31st Annual CIRMS Meeting for a deep dive into cutting-edge radiation measurements and standards. Our very own Nick Brydon will lead a discussion about the "Advantages and limitations of physical and virtual dose mapping of medical devices" on April 30th, 2:30 PM. We're excited to be a part of this opportunity to engage with industry, academia, and government stakeholders in a conversation shaping the future of disruptive technologies in radiation! https://lnkd.in/eJBfxFke #CIRMS2024 #RadiationMeasurements #MedicalDeviceInnovation #DoseMapping
To view or add a comment, sign in
-
-
Wonderful days at the 7th CAR T Symposium in Lille. From basic science on how mitochandrial transfer may improve CAR T fitness to physicians sharing data from CAR T clinical trials and discussions on point of care vs centralized CAR T production. #celltherapy #immunotherapy #cartcelltherapy
To view or add a comment, sign in
-